Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Edwards MS et al. - The efficacy of contemporary revascularization therapies in the treatment of aRVD is unproven and controversial, with no level I data to support current practices. Lower-level data suggest that kidney function improvement is a key indicator of subsequent improved survival free of adverse cardiovascular events and dialysis, and that observed improvements of hypertension confer, at best, limited benefit.

Related Articles

Potential renovascular hypertension, space missions, and the role of magnesium
International Journal of Nephrology and Renovascular Disease, 11/19/09    Relevance Score: 84%

Epidemiology and Natural History of Atherosclerotic Renovascular Disease
Progress in Cardiovascular Diseases, 11/20/09    Relevance Score: 83%

Role of Renal Function and Cardiac Biomarkers (NT-proBNP and Troponin) in Determining Mortality and Cardiac Outcome in Atheromatous Renovascular Disease
Kidney and Blood Pressure Research, 11/05/09    Relevance Score: 82%

Imaging in the evaluation of renovascular disease
Pediatric Nephrology, 10/28/09    Relevance Score: 82%

Atherosclerotic renovascular disease in the United States
Kidney International, 10/30/09    Relevance Score: 80%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address